NCT00236275View on ClinicalTrials.gov

PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

Fluoro-L-thymidine-(18F)

Fluoro-L-thymidine-(18F)

Trial Locations (1)

75020

Hôpital TENON, Paris

All Listed Sponsors
collaborator

Pierre and Marie Curie University

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00236275 - PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer | Biotech Hunter | Biotech Hunter